OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Defending Antiviral Cationic Amphiphilic Drugs That May Cause Drug-Induced Phospholipidosis
Thomas R. Lane, Sean Ekins
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4125-4130
Open Access | Times Cited: 14
Thomas R. Lane, Sean Ekins
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4125-4130
Open Access | Times Cited: 14
Showing 14 citing articles:
Genome-scale CRISPR screens identify host factors that promote human coronavirus infection
Marco Grodzki, Andrew P. Bluhm, Moritz Schaefer, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Marco Grodzki, Andrew P. Bluhm, Moritz Schaefer, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 M pro /3CL pro in Living Cells
Seyed Arad Moghadasi, Morgan A. Esler, Yuka Otsuka, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 26
Seyed Arad Moghadasi, Morgan A. Esler, Yuka Otsuka, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 26
Pyronaridine Protects against SARS-CoV-2 Infection in Mouse
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 6, pp. 1147-1160
Open Access | Times Cited: 22
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 6, pp. 1147-1160
Open Access | Times Cited: 22
Potential use of the cholesterol transfer inhibitor U18666A as an antiviral drug for research on various viral infections
Marjan Assefi, Reza Bijan Rostami, Menooa Ebrahimi, et al.
Microbial Pathogenesis (2023) Vol. 179, pp. 106096-106096
Closed Access | Times Cited: 12
Marjan Assefi, Reza Bijan Rostami, Menooa Ebrahimi, et al.
Microbial Pathogenesis (2023) Vol. 179, pp. 106096-106096
Closed Access | Times Cited: 12
Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders
Saman Yasamineh, Fatemeh Jabbari Mehrabani, Ehsan Derafsh, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3503-3527
Closed Access | Times Cited: 6
Saman Yasamineh, Fatemeh Jabbari Mehrabani, Ehsan Derafsh, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3503-3527
Closed Access | Times Cited: 6
Developing Small-Molecule Inhibitors of Protein-Protein Interactions Involved in Viral Entry as Potential Antivirals for COVID-19
Péter Buchwald
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 11
Péter Buchwald
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 11
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells
David A. Ostrov, Andrew P. Bluhm, Danmeng Li, et al.
Pathogens (2021) Vol. 10, Iss. 11, pp. 1514-1514
Open Access | Times Cited: 13
David A. Ostrov, Andrew P. Bluhm, Danmeng Li, et al.
Pathogens (2021) Vol. 10, Iss. 11, pp. 1514-1514
Open Access | Times Cited: 13
The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
Ana C. Puhl, Thomas R. Lane, Fabio Urbina, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 8
Ana C. Puhl, Thomas R. Lane, Fabio Urbina, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 8
Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques
Francesca Serena Abatematteo, María Majellaro, Bianca Montsch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 3798-3817
Open Access | Times Cited: 4
Francesca Serena Abatematteo, María Majellaro, Bianca Montsch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 3798-3817
Open Access | Times Cited: 4
Learning from COVID-19: How drug hunters can prepare for the next pandemic
Ana C. Puhl, Thomas R. Lane, Sean Ekins
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103723-103723
Open Access | Times Cited: 3
Ana C. Puhl, Thomas R. Lane, Sean Ekins
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103723-103723
Open Access | Times Cited: 3
Antiviral Potential of Azelastine against Major Respiratory Viruses
Katrin Fischhuber, Zoltán Bánki, Janine Kimpel, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2300-2300
Open Access | Times Cited: 3
Katrin Fischhuber, Zoltán Bánki, Janine Kimpel, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2300-2300
Open Access | Times Cited: 3
AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis
Maria Cristina Lomuscio, Carmen Abate, Domenico Alberga, et al.
Molecular Pharmaceutics (2023) Vol. 21, Iss. 2, pp. 864-872
Open Access | Times Cited: 2
Maria Cristina Lomuscio, Carmen Abate, Domenico Alberga, et al.
Molecular Pharmaceutics (2023) Vol. 21, Iss. 2, pp. 864-872
Open Access | Times Cited: 2
Pyronaridine Protects Against SARS-CoV-2 in Mouse
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 3
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 3
Magic bullets, magic shields, and antimicrobials in between
Praveen Prathapan
Pharmaceutical Science Advances (2022) Vol. 1, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 2
Praveen Prathapan
Pharmaceutical Science Advances (2022) Vol. 1, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 2
